Document ID: chunk:federal_register_of_legislation:F2018L00193:reg:9:p2
Version: federal_register_of_legislation:F2018L00193
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 6048–6756

at least 1.5 grams per day, within the three months before the clinical onset of toxic retinopathy; or
(b)          being treated with intravenous paclitaxel or docetaxel within the three months before the clinical onset of toxic retinopathy;
Note: cystoid macular oedema is defined in the Schedule 1 - Dictionary.
(15)      for cystoid macular oedema only, in an aphakic or pseudophakic eye only, being treated with topical adrenaline eye drops, within the three months before the clinical onset of toxic retinopathy;
Note: cystoid macular oedema and aphakic or pseudophakic eye are defined in the Schedule 1 - Dictionary.
(16)      inability to obtain appropriate clinical management for toxic retinopathy.